Recurrent C. Difficile Infection
3 clinical trials · Condition
◉ Watch Recurrent C. Difficile Infection
| Record | Firm | Date |
|---|---|---|
| A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4) (NCT05153499) | Finch Research and Development LLC. | 2021-11-15 |
| Rescue FMT with Bezlotoxumab for Recurrent C. Difficile Infection (NCT06669936) | Alexander Khoruts | 2018-05-01 |
| Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI) (NCT03298048) | The University of Texas Health Science Center, Houston | 2017-12-21 |
Track Recurrent C. Difficile Infection automatically
Every clearance here is in the API, with alerts when new ones post.